Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Series C Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Series C Redeemable Convertible Preferred Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Series C Redeemable Convertible Preferred Stock
Total
Beginning Balance at Dec. 31, 2019   $ 3   $ 203,492 $ (263,474)     $ (59,979)
Beginning Balance (in shares) at Dec. 31, 2019   34,197,822            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (18,367)     (18,367)
Other comprehensive income           $ 3,856   3,856
Stock-based compensation       672       672
Issuance of Series C redeemable convertible preferred stock     $ 4,714       $ 4,714  
Issuance of Series C redeemable convertible preferred stock (in shares) 671,836              
Conversion of convertible notes to Series C redeemable convertible preferred stock     1,436       1,436  
Conversion of convertible notes to Series C redeemable convertible preferred stock (in shares) 198,750              
Vesting of restricted stock awards issued for acquisitions (in shares)   472,141            
Issuance of common stock warrants       44       44
Exercise of stock options       1       1
Exercise of stock options (in shares)   8,409            
Ending Balance at Mar. 31, 2020   $ 3   210,359 (281,841) 3,856   (67,623)
Ending Balance (in shares) at Mar. 31, 2020   35,548,958            
Beginning Balance at Dec. 31, 2019   $ 3   203,492 (263,474)     (59,979)
Beginning Balance (in shares) at Dec. 31, 2019   34,197,822            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss               (33,548)
Ending Balance at Sep. 30, 2020   $ 3   212,999 (296,884)     (83,882)
Ending Balance (in shares) at Sep. 30, 2020   35,973,151            
Beginning Balance at Mar. 31, 2020   $ 3   210,359 (281,841) 3,856   (67,623)
Beginning Balance (in shares) at Mar. 31, 2020   35,548,958            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (6,258)     (6,258)
Other comprehensive income           (3,856)   (3,856)
Stock-based compensation       362       362
Issuance of common stock for acquisitions       39       39
Issuance of common stock for acquisitions (in shares)   11,744            
Exercise of stock options (in shares)   1,174            
Ending Balance at Jun. 30, 2020   $ 3   210,760 (288,099)     (77,336)
Ending Balance (in shares) at Jun. 30, 2020   35,561,876            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (8,923)     (8,923)
Stock-based compensation       507       507
Issuance of Series C redeemable convertible preferred stock     $ 122       $ 122  
Issuance of Series C redeemable convertible preferred stock (in shares) 10,703              
Repurchase of redeemable convertible stock       (480)       (480)
Repurchase of redeemable convertible stock (in shares)   (75,162)            
Issuance of common stock for acquisitions       1,790       1,790
Issuance of common stock for acquisitions (in shares)   396,713            
Shareholder contribution       300       300
Exercise of stock options         138     138
Exercise of stock options (in shares)   79,021            
Ending Balance at Sep. 30, 2020   $ 3   212,999 (296,884)     (83,882)
Ending Balance (in shares) at Sep. 30, 2020   35,973,151            
Beginning Balance at Dec. 31, 2020   $ 8   424,823 (317,506)     107,325
Beginning Balance (in shares) at Dec. 31, 2020   81,669,151            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (65,101)     (65,101)
Stock-based compensation       4,462       4,462
Stock-based compensation - earnout       12,373       12,373
Issuance of common stock for acquisitions       1,169       1,169
Issuance of common stock for acquisitions (in shares)   90,000            
Reclassification of earnout liability upon vesting       25,815       25,815
Vesting of restricted stock units (in shares)   2,078,102            
Exercise of stock warrants   $ 1   93,007       93,008
Exercise of stock warrants (in shares)   8,087,623            
Exercise of stock options       355       355
Exercise of stock options (in shares)   593,106            
Income tax withholdings       (16,997)       (16,997)
Income tax withholdings (in shares)   (1,062,250)            
Transaction costs       (402)       (402)
Ending Balance at Mar. 31, 2021   $ 9   544,605 (382,607)     162,007
Ending Balance (in shares) at Mar. 31, 2021   91,455,732            
Beginning Balance at Dec. 31, 2020   $ 8   424,823 (317,506)     107,325
Beginning Balance (in shares) at Dec. 31, 2020   81,669,151            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss               (86,497)
Ending Balance at Sep. 30, 2021   $ 10   596,156 (404,003) 113   192,276
Ending Balance (in shares) at Sep. 30, 2021   97,332,998            
Beginning Balance at Mar. 31, 2021   $ 9   544,605 (382,607)     162,007
Beginning Balance (in shares) at Mar. 31, 2021   91,455,732            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (16,297)     (16,297)
Other comprehensive income           267   267
Stock-based compensation       2,466       2,466
Stock-based compensation - earnout       4,176       4,176
Issuance of common stock for acquisitions       21,687       21,687
Issuance of common stock for acquisitions (in shares)   1,292,441            
Contingent consideration for acquisitions       6,685       6,685
Reclassification of private warrant liability upon exercise       16,843       16,843
Vesting of restricted stock units (in shares)   33,182            
Exercise of stock warrants   $ 1   33,761       33,762
Exercise of stock warrants (in shares)   2,862,312            
Exercise of stock options       2,227       2,227
Exercise of stock options (in shares)   946,392            
Income tax withholdings       (5,194)       (5,194)
Income tax withholdings (in shares)   (296,643)            
Transaction costs       140       140
Ending Balance at Jun. 30, 2021   $ 10   627,396 (398,904) 267   228,769
Ending Balance (in shares) at Jun. 30, 2021   96,293,416            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (5,099)     (5,099)
Other comprehensive income           (154)   (154)
Stock-based compensation       1,641       1,641
Stock-based compensation - earnout       4,243       4,243
Issuance of common stock for acquisitions       1,937       1,937
Issuance of common stock for acquisitions (in shares)   102,636            
Reclassification of private warrant liability upon exercise       14,505       14,505
Vesting of restricted stock units (in shares)   271,432            
Exercise of stock warrants (in shares)   557,816            
Exercise of stock options       934       934
Exercise of stock options (in shares)   339,150            
Income tax withholdings       (1,587)       (1,587)
Income tax withholdings (in shares)   (231,452)            
Capped call transactions       (52,913)       (52,913)
Ending Balance at Sep. 30, 2021   $ 10   $ 596,156 $ (404,003) $ 113   $ 192,276
Ending Balance (in shares) at Sep. 30, 2021   97,332,998